Genetic
Screening
for Cancer

Genetic Screening for Cancer

test4cancer - samples processed using Illumina Novoseq 6000 Sequencers
Illumina NovoSeq 6000 Sequencer

The most frightening part about cancer is its unpredictability — it can develop in anyone at any point in time, and by the time it does get detected, it’s a late-stage disease.

At Test for Cancer, we use the very latest in genetic cancer screening technology to screen individuals for cancer. Our tests has been designed to help people understand their risk of cancer, especially for those people who are classed as high-risk individuals i.e., those with a family history of cancer, exposed to carcinogens in the workplace, excessive smoking etc…By people understanding their risk of cancer it may be possible for them to take proactive steps and preventative measures to reduce the likelihood of cancer developing.

Early detection and diagnosis of cancer is essential to improving an individual’s chance of survival. At Test for Cancer, we continually strive to give that individual that chance.

HrC Genomics

At Test for Cancer we use HrC Genomics, a simple blood test, to monitor the risk of cancer presence.

HrC Genomics represents a remarkable breakthrough in cancer diagnostics in that it is the first test for cancer that can detect absence or risk of cancer presence from a simple blood sample.

HrC Genomics has been designed to target genetic biomarkers known to be key hallmarks of cancer initiation. But what does this mean to someone taking the test? It means that HrC Genomics can track cancer from the point of initiation i.e., prior to symptoms and tumour development. It is also the first technology that gives a positive result for when cancer is not present i.e., when an individual is cancer free.

Designed to be used as an annual screening test, HrC Genomics will either give an individual the all-clear each year or catch cancer at the earliest stage possible. The aim is turn cancer into an early stage disease when it is at its most weakest. Our vision is to make HrC technology as accessible to as many people as possible. This way, we will beat cancer, one test at a time.

The Ultimate Cancer Screening Test

  • Early Cancer Detection Technology i.e., can detect cancer presence at Stage 1 or before.
  • Only test to give a reading when cancer is NOT present.
  • Indicates risk of cancer being present for multiple cancer types.
  • Designed to be used as an annual screening test to monitor ongoing risk of cancer.
  • Samples processed using Next Generation Sequencing (NGS) technology.
  • Targets genetic biomarkers known to be key hallmarks of cancer initiation.
  • Requires a 12ml sample of blood taken by a Professional Phlebotomist at an approved location.

All Organ Biopsy

HrC Genomics is the ideal cancer screening test due to its remarkable accuracy and reliability of highlighting an individuals risk of cancer presence. However, HrC Genomics is unable to provide detailed information about the cancer detected. For this there is a follow-on test, the All Organ Biopsy (AOB).

Simple Blood Test, Amazing Results

  • A complete and thorough health check of the body’s major organs in relation to cancer.
  • Identification of genetic mutations, altered expressions & dysregulated pathways.
  • Details of tumour(s) location(s), stage of disease and Type & Sub-type of tumours present.
  • Identifies Primary and secondary organs impacted. Indicates next organ to be impacted (if any).
  • Comprehensive report issued detailing all the results with suggestions for cancer treatment dependent upon a patient’s DNA profile.
  • Can be used to monitor responsiveness to cancer treatment.
  • Can be used to conclusively confirm remission in cancer survivors.
  • Samples processed using Next Generation Sequencing (NGS) technology.
  • Requires a 12ml sample of blood taken by a Professional Phlebotomist at one of our approved locations in London.

Stronger Together